Search This Blog

Thursday, October 24, 2019

West Pharmaceutical EPS beats by $0.08, beats on revenue

West Pharmaceutical (NYSE:WST): Q3 Non-GAAP EPS of $0.79 beats by $0.08; GAAP EPS of $0.75 beats by $0.06.
Revenue of $456.1M (+5.7% Y/Y) beats by $6.07M.
Press Release
https://seekingalpha.com/news/3508904-west-pharmaceutical-eps-beats-0_08-beats-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)